Pathophysiology of AHF (acute heart failure)

AHF is a 1-2-3 cascade to acute damage

  • AHF is a complex pathophysiologic process that can be divided into 3 distinct phases that can result in
    acute damage1:
    1. Initiation
    2. Amplification
    3. Damage

Biomarkers may be useful in diagnosing and establishing prognosis or disease severity of AHF1,2


  1. Mann DL, Zipes DP, Libby P, Bonow RO, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, PA: Saunders; 2015.
  2. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240-e327.
  3. Lassus JP, Nieminen MS, Peuhkurinen K, et al; for FINN-AKVA study group. Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J. 2010;31(22):2791-2798.
  4. Cotter G, Milo O, Davison BA. Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond. Curr Heart Fail Rep. 2014;11(1):19-30.
  5. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Javed Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol. 2012;60(16):1455-1469.
  6. Halls ML, Bathgate RA, Summers RJ. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanism. Mol Pharmacol. 2006;70(1):214-226.
  7. Failli P, Nistri S, Quattrone S, et al. Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells. FASEB J. 2002;16(2):252-254.
  8. Jin ZG, Ueba H, Tanimoto T, Lungu AO, Frame MD, Berk MC. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res. 2003;93(4):354-363.
  9. Ignjatovic T, Stanisavljevic S, Brovkovych V, Skidgel RA, Erös EG. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by antiotensin I-converting enzyme inhibitors and peptide ligands. Mol Pharmacol. 2004;66(5):1310-1316.
  10. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147(2):331-338.
  11. Nikolaou M, Parissis J, Yilmaz MB, et al. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J. 2013;34(10):742-749.
  12. Manzano-Fernández S, Januzzi JL Jr, Boronat-Garcia M, et al. ß-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure. J Am Coll Cardiol. 2011;57(7):849-858.
  13. Peacock WF IV, De Marco T, Fonarow GC, et al; for ADHERE Investigators. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358(20):2117-2126.
  14. Eurlings LW, Sanders-van Wijk S, van Kraaij DJW, et al. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA Study. J Card Fail. 2014;20(12):881-890.
  15. Kociol RD, Horton JR, Fonarow GC, et al. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail. 2011;4(5):628-636.
  16. Bettencourt P, Azevedo A, Pimenta J, Friões F, Ferreira S, Ferreira A. N-terminal–pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004;110(15):2168-2174.
  17. You JJ, Austin PC, Alter DA, Ko DT, Tu JV. Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J. 2007;153(4):462-470.
  18. Shirakabe A, Hata N, Kobayashi N, et al. Long-term prognostic impact after acute kidney injury in patients with acute heart failure. Int Heart J. 2012;53(5):313-319.
  19. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290(19):2581-2587.
  20. Chang PP, Chambless LE, Shahar E, et al. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2014;113(3):504-510.